Michigan Initial Experience Using Tigertriever for Thrombectomy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHenry Ford Health System

About this trial

The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.

Tigertriever was used as the first line treatment in the target vessel.

A signed informed consent.

Age ≥ 18.

Disqualifiers

None

Trial population

The registry will include male or female subjects age \> 18 who present with LVO and are treated with the Tigertriever as per the approved indication.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Mechanical Thrombectomy

    Procedure/Surgery

    You will be asked to provide medical history, take neurological exams in the form of questionnaires, and provide imaging data.

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Thrombectomy Treated Patients1 intervention

Trial outcomes

Primary outcomes

1

Modified Rankin Scale

Percentage of participants with a modified Rankin Scale (mRS) score ≤2

Time frame
From enrollment to 90 days post treatment
2

Primary Effectiveness Endpoint

Percentage of participants with a mTICI Score ≥IIb

Time frame
By the end of the thrombectomy procdure.
3

Primary Effectiveness Endpoint - mTICI

Percentage of participants with a mTICI Score ≥IIb after the first pass

Time frame
From time of event to after the first thrombectomy pass.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.